Timing Of New Rules For Long-Listed Products To Be Discussed – FPMAJ
This article was originally published in PharmAsia News
Executive Summary
The Chairman of the Federation of Pharmaceutical Manufacturers’ Associations of Japan and Executive Officer Of Shionogi Pharmaceuticals Yoshiaki Kamoya described discussions he had with the Central Social Insurance Medical Council’s Special Committee of Drug Prices about the new rules concerning prices of long-listed products.